ANZALONE CHRISTOPHER RICHARD (Chief Executive Officer) sold 2.2% of their position (85K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $5.44M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/19/2025ACC: 0001423029-25-000005
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-85K
Net shares
Net seller
$5.44M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
85K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−46.29K
Price / share
$63.55
Trade value
$2.94M
% of position
1.2%
12/17/2025
3.92M→3.87M
Common Stock
Direct
Shares
−35.75K
Price / share
$64.51
Trade value
$2.31M
% of position
0.9%
12/17/2025
3.87M→3.83M
Common Stock
Direct
Shares
−982.00
Price / share
$65.53
Trade value
$64.35K
% of position
0.0%
12/17/2025
3.83M→3.83M
Common Stock
Direct
Shares
−1.98K
Price / share
$66.30
Trade value
$131.34K
% of position
0.1%
12/17/2025
3.83M→3.83M
Total
Net shares
−85K
Net value
-$5.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2025 | S · Sale | −46.29K | $63.55 | $2.94M | 1.2% | 3.92M | 3.87M |
| Common Stock Direct | 12/17/2025 | S · Sale | −35.75K | $64.51 | $2.31M | 0.9% | 3.87M | 3.83M |
| Common Stock Direct | 12/17/2025 | S · Sale | −982.00 | $65.53 | $64.35K | 0.0% | 3.83M | 3.83M |
| Common Stock Direct | 12/17/2025 | S · Sale | −1.98K | $66.30 | $131.34K | 0.1% | 3.83M | 3.83M |
| Total | −85K | -$5.44M | ||||||
Derivative Transactions0
No derivative transactions reported